“German drug maker Merck KGaA (MKGAY.PK) announced Monday that it has entered into an agreement with HAPPYneuron, a subsidiary of SBT Group of France, in which Merck will receive an exclusive license to the company’s cognitive remediation training program for people living with multiple sclerosis or MS. Financial terms of the deal were not disclosed.
HAPPYneuron’s cognitive remediation program will be available for inclusion in Merck’s Msdialog platform for use with Rebif (interferon beta-1a)…when deemed beneficial for a patient by his/her healthcare provider. HAPPYneuron is designed to improve cognitive skills through brain training by repeated cognitive game training exercises…
MSdialog is a multi-tenant cloud-based software system for the management of MS that captures and presents patient outcome data to enable better decision-making by patients and providers. MSdialog is currently available in 24 countries.”
To learn more:
- Agreement press release
- Next: Scalable, medication-free relief of cognitive symptoms related to Multiple Sclerosis (MS)
- Mood & Cognition in MS: [What you can do] (opens YouTube video)
- Presentation at 2015 SharpBrains Virtual Summit, including details from similar partnership between Bayer HealthCare and CogniFit